• Something wrong with this record ?

A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function

Z. Riedelová-Reicheltová, R. Kotlín, J. Suttnar, V. Geierová, T. Riedel, P. Májek, JE. Dyr,

. 2014 ; 111 (1) : 79-87.

Language English Country Germany

Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't

The aim of this study was to investigate the structure and function of fibrinogen obtained from a patient with normal coagulation times and idiopathic thrombophilia. This was done by SDS-PAGE and DNA sequence analyses, scanning electron microscopy, fibrinopeptide release, fibrin polymerisation initiated by thrombin and reptilase, fibrinolysis, and platelet aggregometry. A novel heterozygous point mutation in the fibrinogen Aα chain, Phe98 to Ile, was found and designated as fibrinogen Vizovice. The mutation, which is located in the RGDF sequence (Aα 95-98) of the fibrinogen coiled-coil region, significantly affected fibrin clot morphology. Namely, the clot formed by fibrinogen Vizovice contained thinner and curled fibrin fibers with reduced length. Lysis of the clots prepared from Vizovice plasma and isolated fibrinogen were found to be impaired. The lysis rate of Vizovice clots was almost four times slower than the lysis rate of control clots. In the presence of platelets agonists the mutant fibrinogen caused increased platelet aggregation. The data obtained show that natural mutation of Phe98 to Ile in the fibrinogen Aα chain influences lateral aggregation of fibrin protofibrils, fibrinolysis, and platelet aggregation. They also suggest that delayed fibrinolysis, together with the abnormal fibrin network morphology and increased platelet aggregation, may be the direct cause of thrombotic complications in the patient associated with pregnancy loss.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074612
003      
CZ-PrNML
005      
20141008110714.0
007      
ta
008      
141006s2014 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1160/TH13-04-0267 $2 doi
035    __
$a (PubMed)24108601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Riedelová-Reicheltová, Zuzana
245    12
$a A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function / $c Z. Riedelová-Reicheltová, R. Kotlín, J. Suttnar, V. Geierová, T. Riedel, P. Májek, JE. Dyr,
520    9_
$a The aim of this study was to investigate the structure and function of fibrinogen obtained from a patient with normal coagulation times and idiopathic thrombophilia. This was done by SDS-PAGE and DNA sequence analyses, scanning electron microscopy, fibrinopeptide release, fibrin polymerisation initiated by thrombin and reptilase, fibrinolysis, and platelet aggregometry. A novel heterozygous point mutation in the fibrinogen Aα chain, Phe98 to Ile, was found and designated as fibrinogen Vizovice. The mutation, which is located in the RGDF sequence (Aα 95-98) of the fibrinogen coiled-coil region, significantly affected fibrin clot morphology. Namely, the clot formed by fibrinogen Vizovice contained thinner and curled fibrin fibers with reduced length. Lysis of the clots prepared from Vizovice plasma and isolated fibrinogen were found to be impaired. The lysis rate of Vizovice clots was almost four times slower than the lysis rate of control clots. In the presence of platelets agonists the mutant fibrinogen caused increased platelet aggregation. The data obtained show that natural mutation of Phe98 to Ile in the fibrinogen Aα chain influences lateral aggregation of fibrin protofibrils, fibrinolysis, and platelet aggregation. They also suggest that delayed fibrinolysis, together with the abnormal fibrin network morphology and increased platelet aggregation, may be the direct cause of thrombotic complications in the patient associated with pregnancy loss.
650    _2
$a samovolný potrat $x krev $7 D000022
650    _2
$a dospělí $7 D000328
650    _2
$a batroxobin $x metabolismus $7 D012103
650    _2
$a hemokoagulace $7 D001777
650    _2
$a vyšetření krevní srážlivosti $7 D001780
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrin $x metabolismus $7 D005337
650    _2
$a fibrinogen $x genetika $x metabolismus $7 D005340
650    _2
$a fibrinolýza $7 D005342
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a agregace trombocytů $7 D010974
650    _2
$a bodová mutace $7 D017354
650    _2
$a těhotenství $7 D011247
650    _2
$a konformace proteinů $7 D011487
650    _2
$a trombin $x metabolismus $7 D013917
650    _2
$a trombofilie $x krev $x genetika $7 D019851
650    _2
$a časové faktory $7 D013997
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kotlín, Roman
700    1_
$a Suttnar, Jiří
700    1_
$a Geierová, Véra
700    1_
$a Riedel, Tomáš
700    1_
$a Májek, Pavel
700    1_
$a Dyr, Jan Evangelista $u Jan E. Dyr, Institute of Haematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic, Tel.: +420 221 977 208, Fax: +420 221 977 208, E-mail: jan.dyr@uhkt.cz.
773    0_
$w MED00004517 $t Thrombosis and haemostasis $x 0340-6245 $g Roč. 111, č. 1 (2014), s. 79-87
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24108601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141008111102 $b ABA008
999    __
$a ok $b bmc $g 1042495 $s 873524
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 111 $c 1 $d 79-87 $i 0340-6245 $m Thrombosis and haemostasis $n Thromb Haemost $x MED00004517
LZP    __
$a Pubmed-20141006

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...